14-day Premium Trial Subscription Try For FreeTry Free

Biotech Stock Roundup: VIR Down on Regulatory News, BMY Offers Updates & More

05:23pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Regulatory and pipeline news from Vir Biotechnology (VIR) and Bristol Myers (BMY) are a few key highlights from the biotech sector during the past week.

VIR Stock Down on Another Setback for COVID-19 Antibody

04:25pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
VIR and partner Glaxo suffer a setback as the FDA determines that sotrovimab is no longer authorized for use in the United States for COVID-19.
SAN FRANCISCO, April 06, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that a team of three company scientists were named one of the winners of the Pediatric COVID-1

How to Find New Stocks for Your Portfolio

02:00pm, Wednesday, 06'th Apr 2022 The Motley Fool
I like to read articles by people who aren't just bullish -- they've bought shares.
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the 21st Annual Needham Healthcare Con

Why Shares of Vir Biotechnology Rose 20.4% This Week

04:43pm, Friday, 01'st Apr 2022 The Motley Fool
Joining the S&P SmallCap 600 could boost the company's profile.
Joining the S&P SmallCap 600 could boost the company's profile.

Vir Biotechnology, Inc. (VIR) Moves 14.8% Higher: Will This Strength Last?

07:10pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Vir Biotechnology, Inc. (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further streng
Vir Biotechnology, Inc. (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further streng

VIR Stock Gains on News of Inclusion in the S&P SmallCap 600

03:23pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Vir Biotechnology (VIR) shares gain as the company is set to join the S&P SmallCap 600 effective prior to the opening of trading on Monday, Apr 4.
Vir Biotechnology (VIR) shares gain as the company is set to join the S&P SmallCap 600 effective prior to the opening of trading on Monday, Apr 4.

Vir Jumps 20% On S&P SmallCap 600 News

12:25pm, Thursday, 31'st Mar 2022
Currently, 66 ETFs are affected, but it will be added to even more funds soon.
Wall Street ends lower on a modest pullback Wednesday, as investors check their optimism over negotiations between Ukraine and Russia.

Why Vir Biotechnology Stock Is Skyrocketing Today

04:40pm, Wednesday, 30'th Mar 2022 The Motley Fool
The S&P SmallCap 600 index will soon include Vir.

Why Vir Biotechnology Stock Is Skyrocketing Today

12:40pm, Wednesday, 30'th Mar 2022
The S&P SmallCap 600 index will soon include Vir.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE